Background: Psychological stress and anxiety have been shown to produce an activation of coagulation and fibrinolysis. Resulting hypercoagulability is a risk factor for cardiovascular diseases, and could therefore contribute to an increased prevalence of coronary artery disease in anxiety patients. However, hemostasis function has not yet been studied in patients with clinically relevant anxiety disorders. Methods: A group of anxiety patients (panic disorder with agoraphobia or social phobia) and a healthy control group (each n = 29) completed some questionnaires [SCL-K9 (a short form of the SCL-90-R), State Trait Anxiety Inventory, ADS (general depression scale)], and had blood drawn after a 15-min rest period. To assess the reaction of the hemostatic system by global entities, sum scores were computed from parameters of coagulation and fibrinolysis (fibrinogen, FVII, FVIII, vWF, F1 + 2, TAT, D-dimer, α2-AP, PAP, tPA, PAI-1). Interfering variables, such as age, gender, alcohol consumption and smoking status, were controlled. Results: Anxiety patients scored higher in a composite hemostatic score and a sum score of fibrinolysis in comparison to the control group, with a predominant activation of inhibitors in fibrinolysis. However, the psychological variable with the closest association to hemostasis was not trait anxiety, but self-perceived worry about blood drawing before blood sampling was performed. Conclusions: The coagulation and fibrinolysis system is activated in the direction of a hypercoagulable state in patients with severe phobic anxiety, triggered by fear of blood drawing. This could be one mediating factor for the increased risk of cardiovascular diseases in this population. Acute situational phobic anxiety should be monitored closely when studying the association between anxiety and hemostasis.

1.
Hemingway H, Marmot M: Psychosocial factors in the aetiology and prognosis of coronary heart disease: systematic review of prospective cohort studies. BMJ 1999;318:1460–1467.
2.
Benninghoven D, Kaduk A, Wiegand U, Specht T, Kunzendorf S, Jantschek G: Influence of anxiety on the course of heart disease after acute myocardial infarction – risk factor or protective function? Psychother Psychosom 2006;75:56–61.
3.
Sørensen C, Friis-Hasché E, Haghfelt T, Bech P: Postmyocardial infarction mortality in relation to depression: a systematical critical review. Psychother Psychosom 2005;74:69–80.
4.
Denollet J, Strik JJ, Lonsberg R, Hong A: Recognizing increased risk of depression comorbidity after myocardial infarction. Psychother Psychosom 2006;75:346–352.
5.
Rozanski A, Blumenthal JA, Kaplan J: Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 1999;99:2192–2217.
6.
Strike PC, Kesson M, Brydon L, Edwards S, McEwan JR, Steptoe A: Exaggerated platelet and hemodynamic reactivity to mental stress in men with coronary artery disease. Psychosom Med 2004;66:492–500.
7.
von Känel R, Mills PJ, Fainman C, Dimsdale JE: Effects of psychological stress and psychiatric disorders on blood coagulation and fibrinolysis: a biobehavioral pathway to coronary artery disease? Psychosom Med 2001;63:531–544.
8.
Doulalas AD, Rallidis LS, Gialernios T, Moschonas DN, Kougioulis MN, Rizos I, Tselegaridis TS, Kremastinos DT: Association of depressive symptoms with coagulation factors in young healthy individuals. Atherosclerosis 2006;186:121–125.
9.
Pitsavos C, Panagiotakos DB, Papageorgiou C, Tsetsekou E, Soldatos C, Stefanadis C: Anxiety in relation to inflammation and coagulation markers, among healthy adults. The ATTICA Study. Atherosclerosis 2006;185:320–326.
10.
Raikkonen K, Lassila R, Keltikangas-Jarvinen L, Hautanen A: Association of chronic stress with plasminogen activator inhibitor-1 in healthy middle-aged men. Arterioscl Throm Vas 1996;16:363–367.
11.
Folsom AR, Qamhieh HT, Flack JM, Hilner JE, Liu K, Howard BV, Tracy RP: Plasma fibrinogen: levels and correlates in young adults. The Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Epidemiol 1993;138:1023–1036.
12.
von Känel R, Dimsdale JE, Adler KA, Patterson TL, Mills PJ, Grant I: Effects of depressive symptoms and anxiety on hemostatic responses to acute mental stress and recovery in the elderly. Psychiat Res 2004;126:253–264.
13.
von Känel R, Kudielka BM, Schulze R, Gander M-L, Fischer JE: Hypercoagulability in working men and women with high levels of panic-like anxiety. Psychother Psychosom 2004;73:353–360.
14.
Seeman TE, McEwen BS, Rowe JW, Singer BH: Allostatic load as a marker of cumulative biological risk: MacArthur studies of successful aging. Proc Natl Acad Sci USA 2001;98:4770–4775.
15.
Haines AP, Imeson JD, Meade TW: Phobic anxiety and ischemic heart disease. BMJ 1987;295:297–299.
16.
Kawachi I, Colditz GA, Ascherio A, Rimm EB, Giovannucci E, Stampfer MJ, Willett WC: Prospective study of phobic anxiety and risk of coronary heart disease in men. Circulation 1994;89:1992–1997.
17.
Wittchen HU, Zaudig M, Fydrich T: SKID: Strukturiertes Klinisches Interview für DSM-IV: Achse I und II. Göttingen, Hogrefe, 1997.
18.
Klaghofer R, Brähler E: Konstruktion und teststatistische Prüfung einer Kurzform der SCL-90-R. Z Klin Psychol 2001;49:115–124.
19.
Derogatis LR: SCL-90-R : Administration, Scoring, and Procedures Manual-I for the R(evised) Version of the Psychopathology Rating Scale Series. Baltimore, John Hopkins University School of Medicine, 1977.
20.
Laux L, Glanzmann P, Schaffner P, Spielberger CD: Das State-Trait-Angstinventar. Weinheim, Beltz Test, 1981.
21.
Hautzinger M, Bailer M: Die Allgemeine Depressionsskala. Göttingen, Hogrefe, 1993.
22.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders – DSM-IV-TR (ed 4, Text Revision). Washington, APA, 2000.
23.
Radloff LS: The CES-D scale: a self report depression scale for research in the general population. Appl Psychol Meas 1977;1:385–401.
24.
von Känel R, Dimsdale JE, Patterson TL, Grant I: Acute procoagulant stress response as a dynamic measure of allostatic load in Alzheimer caregivers. Ann Behav Med 2003;26:42–48.
25.
von Känel R, Hepp U, Buddeberg C, Keel M, Mica L, Aschbacher K, Schnyder U: Altered blood coagulation in patients with posttraumatic stress disorder. Psychosom Med 2006;68:598–604.
26.
Steptoe A, Kunz-Ebrecht S, Rumley A, Lowe GDO: Prolonged elevations in haemostatic and rheological responses following psychological stress in low socioeconomic status men and women. Thromb Haemost 2003;89:83–90.
27.
Kario K, Matsuo T, Kobayashi H, Yamamoto K, Shimada K: Earthquake-induced potentiation of acute risk factors in hypertensive elderly patients: possible triggering of cardiovascular events after a major earthquake. J Am Coll Cardiol 1997;29:926–933.
28.
Stegnar M, Vene N, Bozic M: Do haemostasis activation markers that predict cardiovascular disease exist? Pathophysiol Haemost Thromb 2003/2004;33:302–308.
29.
Wang HX, Mittleman MA, Leineweber C, Orth-Gomer K: Depressive symptoms, social isolation, and progression of coronary artery atherosclerosis: the Stockholm Female Coronary Artery Angiography Study. Psychother Psychosom 2006;75:96–102.
30.
Fava GA, Grandi S, Saviotti FM, Bartolucci G, Savron G, Conti S: Blood-injury phobia. Am J Psychiatry 1989;146:948–949.
31.
Fava GA, Ruini C, Rafanelli C: Psychometric theory is an obstacle to the progress of clinical research. Psychother Psychosom 2004;73:145–148.
32.
von Känel R, Kudielka BM, Preckel D, Hanebuth D, Herrmann-Lingen C, Frey K, Fischer JE: Opposite effect of negative and positive affect on stress procoagulant reactivity. Physiol Behav 2005;86:61–68.
33.
Aschbacher K, Patterson TL, von Känel R, Dimsdale JE, Mills PJ, Adler KA, Ancoli-Israel S, Grant I: Coping processes and hemostatic reactivity to acute stress in dementia caregivers. Psychosom Med 2006;67:964–971.
34.
Halperin D, Reber G: Influence of antidepressants on hemostasis. Dialogues Clin Neurosci 2007;9:47–59.
35.
Kudriashova OI, Zateishchikov DA, Barinov VG, Privalov DV, Tsimbalova TE, Zateishchikova AA, Rogovaia OM, Sidorenko BA: Gender differences in the state of the system of hemostasis in patients with ischemic heart disease. Kardiologiia 2002;42:29–33.
36.
Kulaputana O, Macko RF, Ghiu I, Phares DA, Goldberg AP, Hagberg JM: Human gender differences in fibrinolytic responses to exercise training and their determinants. Exp Physiol 2005;90:881–887.
37.
Lee KW, Lip GYH: Effects of lifestyle on hemostasis, fibrinolysis, and platelet reactivity: a systematic review. Arch Intern Med 2003;163:2368–2392.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.